PROSPERO: A study to determine the utility of focused genomic profiling to guide selection of drug therapy in salivary gland cancer. Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 ...
Retrospective analysis of 367 patients admitted to two level IV neonatal intensive care units. Linear mixed effects models were developed to evaluate daily census, time of the day, and day of the week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback